Pyridoxine-dependent seizures and cognition in adulthood.
A case report of neonatal onset pyridoxine-dependent seizures in a male patient with early diagnosis and treatment is presented. The patient's epilepsy was recognized and treated with pyridoxine (vitamin B6) within 8 hours of birth. Treatment has been nearly continuous since that time. This paper reports the results of a full neuropsychological evaluation at age 37 years and MRI completed at age 31 years. Consistent with other case reports in the literature, there was a significant Performance IQ (PIQ) advantage with decreased Verbal IQ (VIQ) and expressive language skills (Full-Scale IQ 71, VIQ 64, PIQ 85). MRI demonstrated characteristic thinning of the posterior corpus callosum. This report provides an example of early treatment that nonetheless results in a mild mental retardation. The similarity of the structural changes on MRI and the cognitive profile of this patient to those of others reported in the literature suggest that the underlying mechanism for both may be the same.
Department of Neurology, Center for Neurosciences, University of California, Davis, CA, USA.
Kathleen
K
Baynes
Sarah Tomaszewski
ST
Farias
Sidney M
SM
Gospe
D000328:Adult; D061085:Agenesis of Corpus Callosum; D000927:Anticonvulsants / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000175:diagnosis*; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D008607:Intellectual Disability / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D008297:Male; D009483:Neuropsychological Tests; D011736:Pyridoxine / Q000627:therapeutic use*; D012720:Severity of Illness Index
D000927:Anticonvulsants; D011736:Pyridoxine